Ronnie Shapira-Frommer

5PUBLICATIONS
62CO-AUTHORS
Molecular targetsOral implantologyImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 26, 2026
Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study.

Mariano Ponz-Sarvisé, Sun Young Rha, Carlos A Gomez-Roca

|Nov 15, 2023
Neoadjuvant BRAF-targeted therapy for ameloblastoma of the mandible: an organ preservation approach.

Shirly Grynberg, Marilena Vered, Ronnie Shapira-Frommer

|Aug 31, 2023
Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With Melanoma.

Jack Pepys, Ronen Stoff, Roni Ramon-Gonen

|Apr 19, 2023
MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2.

Ettai Markovits, Ortal Harush, Erez N Baruch

|Dec 11, 2020
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.

Erez N Baruch, Ilan Youngster, Guy Ben-Betzalel

Pageof 1

Frequent Collaborators

4 joint publications

Nethanel Asher

2 joint publications

Ronen Stoff

2 joint publications

Shirly Grynberg

2 joint publications

Jacob Schachter